Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis

Despite substantially elevated risk of serious adverse events (SAEs) from targeted therapy in combination with chemotherapy, comprehensive pharmacovigilance research is limited. This study aims to systematically assess SAE risks of commonly prescribed targeted agents (bevacizumab, cetuximab, and pan...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yeo Jin, Choi, Chang-Young, Rhie, Sandy Jeong, Shin, Sooyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368240/
https://www.ncbi.nlm.nih.gov/pubmed/35954563
http://dx.doi.org/10.3390/ijerph19159196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368240/
https://www.ncbi.nlm.nih.gov/pubmed/35954563
http://dx.doi.org/10.3390/ijerph19159196

Ejemplares similares